NCT02279966 Efficacy of Vortioxetine on Cognitive Dysfunction in Working Patients With Major Depressive Disorder Status COMPLETED Phase PHASE3
NCT02279953 Efficacy of Vortioxetine on Cognitive Dysfunction in Patients With Partial or Full Remission of Major Depressive Disorder Status COMPLETED Phase PHASE3
NCT02272517 Efficacy of Vortioxetine Versus Escitalopram on Cognitive Function in Patients With Inadequate Response to Current Antidepressant Treatment of Major Depressive Disorder Status COMPLETED Phase PHASE3
NCT02269540 A New Treatment Approach for Major Depressive Disorder Based Upon Targeting Monoamine Oxidase A (MAO-A) Status COMPLETED Phase EARLY_PHASE1
NCT02263248 Incomplete Response in Late-Life Depression: Getting to Remission With Buprenorphine Status COMPLETED Phase PHASE1/PHASE2
NCT02238730 Ultrabrief Right Unilateral and Brief Pulse Bitemporal Electroconvulsive Therapy Status WITHDRAWN Phase NA
NCT02218008 A Study of ALKS 5461 for the Treatment of Major Depressive Disorder (MDD) - FORWARD-5 Study Status COMPLETED Phase PHASE3
NCT02209597 Clinical Study of Generic and Brand Bupropion in Depression Status COMPLETED Phase PHASE4
NCT02191124 The Measurement-based Care in Patients With Depressive Disorder: A Randomized Controlled Trial Status COMPLETED Phase PHASE4